These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 15644992
41. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK. J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449 [Abstract] [Full Text] [Related]
42. Nefazodone for chronic daily headache prophylaxis: an open-label study. Saper JR, Lake AE, Tepper SJ. Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644 [Abstract] [Full Text] [Related]
43. Usability, Acceptability, and Adherence to an Electronic Self-Monitoring System in Patients With Major Depression Discharged From Inpatient Wards. Lauritsen L, Andersen L, Olsson E, Søndergaard SR, Nørregaard LB, Løventoft PK, Svendsen SD, Frøkjær E, Jensen HM, Hageman I, Kessing LV, Martiny K. J Med Internet Res; 2017 Apr 21; 19(4):e123. PubMed ID: 28432040 [Abstract] [Full Text] [Related]
44. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN. Depress Anxiety; 2005 Apr 21; 22(2):94-7. PubMed ID: 16094663 [Abstract] [Full Text] [Related]
45. An open trial of nefazodone in adult patients with generalized anxiety disorder. Hedges DW, Reimherr FW, Strong RE, Halls CH, Rust C. Psychopharmacol Bull; 1996 Apr 21; 32(4):671-6. PubMed ID: 8993090 [Abstract] [Full Text] [Related]
46. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036 [Abstract] [Full Text] [Related]
51. Nefazodone in the treatment of severe, melancholic, and recurrent depression. Marcus RN, Mendels J. J Clin Psychiatry; 1996 Sep 01; 57 Suppl 2():19-23. PubMed ID: 8626359 [Abstract] [Full Text] [Related]
52. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Davis R, Whittington R, Bryson HM. Drugs; 1997 Apr 01; 53(4):608-36. PubMed ID: 9098663 [Abstract] [Full Text] [Related]
55. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Amsterdam JD, Wang CH, Shwarz M, Shults J. J Affect Disord; 2009 Jan 01; 112(1-3):219-30. PubMed ID: 18486235 [Abstract] [Full Text] [Related]
56. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS, Ng F, Berk M. Aust N Z J Psychiatry; 2008 Apr 01; 42(4):346-9. PubMed ID: 18330778 [Abstract] [Full Text] [Related]
57. The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder. Dursun SM, Devarajan S, Kutcher S. J Psychopharmacol; 2001 Jun 01; 15(2):136-8. PubMed ID: 11448087 [Abstract] [Full Text] [Related]
58. Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Argyropoulos SV, Hicks JA, Nash JR, Bell CJ, Rich AS, Nutt DJ, Wilson SJ. Psychiatry Res; 2003 Sep 30; 120(2):179-90. PubMed ID: 14527649 [Abstract] [Full Text] [Related]
60. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C. Am J Geriatr Psychiatry; 2013 Aug 30; 21(8):769-84. PubMed ID: 23567397 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]